TY - JOUR
T1 - Immunologially Applicability for Foods of Short Chain Peptides Derived from Sardines
AU - Seki, Eiji
AU - Osajima, Katsuhiro
AU - Matsufuji, Hiroshi
AU - Matsui, Toshiro
AU - Osajima, Yutaka
PY - 1995/1/1
Y1 - 1995/1/1
N2 - Short chain peptides with the average chain length of 2.67 prepared from sardine protein have reductive effects on blood pressure, and are expected to be a physiologically functional foodstuff. The short chain peptides were found to be negative in the active systemic anaphylaxis (ASA) test in guinea pigs sensitized by oral administrations of the short chain peptides. Negative results were also obtained in the homologous passive cutaneous anaphylaxis (PCA) test, which was done against sera from guinea pigs sensitized by oral administration of the short chain peptides. The short chain peptides have a potent angiotensin I converting enzyme (ACE) inhibitory activity, this enzyme catalyses the activation of angijotensin II and inactivation of bradykinin. The bradykinin is able to stimulate macrophages, to enhance lymphocyte migration, and to increase secretion of lymphokines. The short chain peptides favor bradykinin activity, which showed concentrated pigment coloration in the PCA test by subcutaneous sensitization. These results suggest that the short chain peptides have no antigenicity by oral administration, and are usable in foods.
AB - Short chain peptides with the average chain length of 2.67 prepared from sardine protein have reductive effects on blood pressure, and are expected to be a physiologically functional foodstuff. The short chain peptides were found to be negative in the active systemic anaphylaxis (ASA) test in guinea pigs sensitized by oral administrations of the short chain peptides. Negative results were also obtained in the homologous passive cutaneous anaphylaxis (PCA) test, which was done against sera from guinea pigs sensitized by oral administration of the short chain peptides. The short chain peptides have a potent angiotensin I converting enzyme (ACE) inhibitory activity, this enzyme catalyses the activation of angijotensin II and inactivation of bradykinin. The bradykinin is able to stimulate macrophages, to enhance lymphocyte migration, and to increase secretion of lymphokines. The short chain peptides favor bradykinin activity, which showed concentrated pigment coloration in the PCA test by subcutaneous sensitization. These results suggest that the short chain peptides have no antigenicity by oral administration, and are usable in foods.
UR - http://www.scopus.com/inward/record.url?scp=21844500859&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=21844500859&partnerID=8YFLogxK
U2 - 10.1271/nogeikagaku1924.69.1171
DO - 10.1271/nogeikagaku1924.69.1171
M3 - Article
AN - SCOPUS:21844500859
VL - 69
SP - 1171
EP - 1174
JO - Nippon Nogeikagaku Kaishi
JF - Nippon Nogeikagaku Kaishi
SN - 0002-1407
IS - 9
ER -